121804

Could the adverse outcomes of “seasonal influenza” vaccination in South Korea have an effect on the COVID-19 pandemic?

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

Medical virology

Abstract

COVID-19 is a respiratory disease that difficult to differentiate from influenza symptoms. The COVID-19 pandemic has not yet finished and “seasonal influenza" will be coming from December to February. Several countries such as South Korea and Singapore were prepared for the “Flu" vaccination to minimize common influenza disease. Consequently, the COVID-19 pandemic already become a “double attack" if most people are not taken a “Flu" vaccine in the winter of this year, “seasonal influenza" will be killed at least 3,000 South Koreans. It's the same situation in other countries. People have a high risk of getting “Flu" as well as developing the COVID-19 complications, so it should be vaccinated with the seasonal influenza vaccine for prevention.
Nonetheless, there is another issue that occurred in South Korea. According to the South Korean Disease Control and Prevention Agency (KDCA) reported, it has at least 59 people died after injection of the “Flu" vaccine. Why did this happen? Did any safety issues appear in the vaccine? The “Flu" vaccine has been proven to be safe with rare side effects such as people may get Guillain-Barré Syndrome (GBS) causing muscle weakness and paralysis which is around one in a million chance. It is very rare for anyone to have a serious allergic reaction (anaphylaxis). Thus, people died after getting “Flu" vaccine shots, they are 60 years old or above with pre-existing health problems and chronic diseases including hypertension, heart disease, stroke, respiratory diseases, and diabetes. (To be continued)...

DOI

10.21608/mid.2020.48202.1081

Keywords

“Seasonal influenza”, “COVID-19” outbreak, “Flu” vaccine

Authors

First Name

Siukan

Last Name

Law

MiddleName

-

Affiliation

Department of Science, School of Science and Technology, The Open University of Hong Kong, Ho Man Tin, Kowloon, Hong Kong

Email

siukanlaw@hotmail.com

City

-

Orcid

0000-0002-0454-2048

First Name

Albert Wingnang

Last Name

Leung

MiddleName

-

Affiliation

School of Graduate Studies, Lingnan University, Tuen Mun, Hong Kong

Email

albertleung@ln.edu.hk

City

-

Orcid

-

First Name

Chuanshan

Last Name

Xu

MiddleName

-

Affiliation

Key Laboratory of Molecular Target and Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, China

Email

xcshan@163.com

City

-

Orcid

-

Volume

2

Article Issue

1

Related Issue

19260

Issue Date

2021-02-01

Receive Date

2020-10-03

Publish Date

2021-02-01

Page Start

3

Page End

4

Print ISSN

2682-4132

Online ISSN

2682-4140

Link

https://mid.journals.ekb.eg/article_121804.html

Detail API

https://mid.journals.ekb.eg/service?article_code=121804

Order

2

Type

Letter to the Editor

Type Code

1,165

Publication Type

Journal

Publication Title

Microbes and Infectious Diseases

Publication Link

https://mid.journals.ekb.eg/

MainTitle

Could the adverse outcomes of “seasonal influenza” vaccination in South Korea have an effect on the COVID-19 pandemic?

Details

Type

Article

Created At

22 Jan 2023